A5103031188- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Corneal surgery and disorders
- Ocular Surface and Contact Lens
- Intraocular Surgery and Lenses
- Ophthalmology and Eye Disorders
- Ocular Infections and Treatments
- Retinal Imaging and Analysis
- Retinal and Macular Surgery
- Cancer Research and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Antifungal resistance and susceptibility
- Ocular Diseases and Behçet’s Syndrome
- Cardiovascular Health and Disease Prevention
- Diabetic Foot Ulcer Assessment and Management
- Traumatic Brain Injury and Neurovascular Disturbances
- Optical Imaging and Spectroscopy Techniques
- Cerebral Venous Sinus Thrombosis
- Renal Diseases and Glomerulopathies
- Aortic aneurysm repair treatments
- Science, Research, and Medicine
- Advanced Drug Delivery Systems
- Coronary Interventions and Diagnostics
- Chromosomal and Genetic Variations
- Legionella and Acanthamoeba research
University of Turin
2016-2025
Piedmont Reference Center for Epidemiology and Cancer Prevention
2024
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2020
Ospedale Sant'Anna
2016
Cancer Research Center
2005-2007
To assess the safety and efficacy of one, two, or three trabecular microbypass stents in eyes with primary open-angle glaucoma (OAG) not controlled on ocular hypotensive medication. A total 119 subjects were followed for 18 months postoperatively.Subjects medicated intraocular pressure (IOP) 18-30 mmHg postmedication-washout baseline IOP 22-38 randomized to implantation stents. Ocular medication was be used if postoperative exceeded mmHg.A 38 implanted one stent, 41 two stents, 40 Both month...
Evaluate long-term outcomes after one, two, or three trabecular micro-bypass stents implanted in a standalone procedure eyes with open-angle glaucoma taking ocular hypotensive medication.Prospective randomized ongoing study of 119 subjects (109 42-month follow-up) glaucoma, preoperative intraocular pressure (IOP) 18-30 mmHg on one to medications, and unmedicated (post-washout) IOP 22-38 mmHg. Subjects were receive (n=38), two (n=41), (n=40) iStent procedure. Postoperatively, was measured...
Purpose. To report the long-term follow-up results in patients with cataract and primary open-angle glaucoma (POAG) randomly assigned to surgery combined micro-bypass stent implantation or phacoemulsification alone. Methods. 36 subjects POAG were randomized a 1 : 2 ratio either iStent (combined group) alone (control group). 24 agreed be evaluated again 48 months after surgery. Patients returned one month later for unmedicated washout assessment. Results. At visit we reported mean IOP of 15,9...
To compare the reduction of intraocular pressure (IOP) and glaucoma medications following selective laser trabeculoplasty (SLT) versus stand-alone placement Hydrus microstent, a microinvasive surgery device.Prospective interventional case-series. University practice.Fifty six eyes (56 patients) with uncontrolled primary open-angle glaucoma.Patients received either SLT (n = 25) or implantation 31) in two centres. Patients were evaluated at baseline 1, 7 days, 3, 6 12 months after...
Objective. To evaluate the efficacy and safety of Xen Gel Stent provide a macro- microscopic analyses bleb morphology. Methods . A prospective 12-month study on patients with primary open-angle glaucoma. Patients underwent implantation XEN (Allergan INC, Dublin, Ireland) either alone or combined cataract surgery. Biomicroscopy, in vivo confocal microscopy (IVCM), anterior segment-optical coherence tomography (AS-OCT) were used to assess Safety parameters adverse events, best corrected visual...
To evaluate the effectiveness and safety of Preserflo MicroShunt implant (Santen) in patients with primary open-angle glaucoma (POAG) pseudoexfoliation (PXG). Retrospective, open-label, multicenter study. Patients insufficiently controlled POAG or PXG who underwent a standalone implantation procedure. Consecutive surgery ab externo minimally invasive device mitomycin C. Primary end points were mean change intraocular pressure (IOP) number hypotensive medications from baseline through month...
Aim To compare the gel stent to trabeculectomy in Gold-Standard Pathway Study (GPS) patients with primary open-angle glaucoma (POAG). Methods In GPS, elevated intraocular pressure (IOP) poorly controlled IOP-lowering medication were randomised (2:1, stent:trabeculectomy). Aggregate endpoint: (%) at month 12 achieving ≥20% IOP reduction from baseline without increase, clinical hypotony, vision loss counting fingers or secondary surgical intervention (SSI). Secondary endpoints included changes...
Abstract Purpose To establish expert consensus on guidelines for implementing glaucoma virtual clinics in Italy, focusing patient suitability, essential clinical assessments and staffing requirements. Methods A modified Delphi method was used to achieve among selected Italian specialists. The steering group developed a structured questionnaire with 66 items across key areas: Patient Categories, Clinical Assessments, Roles Staffing Guidelines clinic implementation. panel of experts reviewed...
Abstract Objectives To evaluate the 1-year effectiveness and safety of XEN45, either alone or in combination with phacoemulsification, glaucoma patients. Methods This multicentre, prospective, observational study included consecutive eyes patients from Italian XEN-Glaucoma Treatment Registry (XEN-GTR) who underwent XEN45 at least 1 year follow-up. Surgical success was defined as intraocular pressure (IOP) < 18 mmHg ≥20% reduction preoperative IOP, over Results Two hundred thirty-nine (239...
Purpose. To compare the corneal endothelial cell loss after phacoemulsification, alone or combined with microinvasive glaucoma surgery (MIGS), in nonglaucomatous versus primary open angle (POAG) eyes affected by age-related cataract. Methods. 62 of patients were divided into group 1 (n = 25, cataract) and 2 37, cataract POAG). All underwent surgery. Group was subgroups A 19, alone) B 18, MIGS). Prior to 6 months patients' endothelium studied. Main outcomes CD (cell density), SD (standard...
Endophthalmitis is a rare, but serious, intravitreal inflammatory disorder that can arise after cataract surgery. The intracameral injection of 1 mg cefuroxime (CEF) followed by three-times daily antibiotic topical administration for week generally recognized as the routine method prophylaxis This procedure controversial because both low efficacy and adherence to therapy elderly patients. A unique slow release could solve these problems. objective present study was design ophthalmic...
This study reports on the safety and efficacy of Xen 45 in patients with glaucoma high myopia. It was a retrospective including myopia (>6D) who underwent implant 2 years follow-up. The primary outcome to report incidence hypotony (IOP ≤ 5 mmHg) hypotony-related complications. Patients treated mitomycin-C-augmented trabeculectomy were included as control group. We 14 consecutive (seven eyes) eyes). mean -14.71 ± 5.36 -15.07 6.11 groups, respectively (p > 0.05). success rate IOP at 1 from...
The new XEN63 implant is a minimally invasive glaucoma surgery device with limited experience in real life. This retrospective study included open-angle patients who underwent implant, either alone or combination cataract surgery. Primary endpoints were the intraocular pressure (IOP) at month 3 and incidence of serious adverse events. Twenty-three eyes 23 included. Mean age was 67.8 ± 15.3 years 15 (65.2%) women. IOP significantly lowered from 27.0 7.8 mmHg baseline to 12.2 3.4 (p <...
Abstract Background Glaucoma is a disease characterized by progressive damage of the optic nerve. Several therapeutic options are available to lower intraocular pressure (IOP). In primary open-angle glaucoma (POAG) patients with inadequate IOP control (or controlled multiple medical therapies or for whom therapy contraindicated), implantation micro-invasive surgery devices (MIGS) and concomitant cataract has proved be more effective in reducing (IOP), as compared alone. The objective this...
Background: Glaucoma surgery has significantly evolved over the last years. This paper aims to evaluate midterm clinical outcomes of XEN63 device in a real-world scenario. Methods: A retrospective study was conducted on consecutive patients who underwent an implant insertion, either alone or combination with phacoemulsification. The primary endpoint mean intraocular pressure (IOP) at month 18 visit. Results: Twenty-three eyes (23 patients) were included analysis. preoperative IOP lowered...
There is a lack of information about long-term results chronic angle closure glaucoma following an acute primary attack in Caucasian patients.The aim the study was to report morphological and functional data eyes monolateral provide comparison with their fellow eyes.Observational retrospective case series.Fifty-seven consecutive patients (114 eyes) underwent follow-up analysis.Patients ophthalmic assessment more than 5 years since attack.Intraocular pressure, best-corrected visual acuity,...